Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Pharma & Healthcare
Published Date: 2025-09-11
Pages: 146 Pages
Report ld: 5044077
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Prothrombin Complex Market Size(US$)
CAGR 2025-2031
11.8%
Market Size,2031
USD 4,251
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,177 million
Market Forecast in 2031(Value)
US$ 4,251 million
CAGR
11.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human Prothrombin Complex market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Segment by Application
- Hemophilia B
- Vitamin K Deficiency
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Human Prothrombin Complex study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Human Prothrombin Complex: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human Prothrombin Complex Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 16 IU/Vial
1.2.3 18 IU/Vial
1.2.4 20 IU/Vial
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Human Prothrombin Complex Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Prothrombin Complex Revenue Estimates and Forecasts 2020-2031
2.2 Global Human Prothrombin Complex Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Human Prothrombin Complex Sales Estimates and Forecasts 2020-2031
2.4 Global Human Prothrombin Complex Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Human Prothrombin Complex Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Human Prothrombin Complex Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 22 IU/Vial Market Size by Manufacturers
3.5.2 24 IU/Vial Market Size by Manufacturers
3.5.3 26 IU/Vial Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Human Prothrombin Complex Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human Prothrombin Complex Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Human Prothrombin Complex Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human Prothrombin Complex Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Human Prothrombin Complex Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Human Prothrombin Complex Sales and Revenue by Type (2020-2031)
6.4 North America Human Prothrombin Complex Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human Prothrombin Complex Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Human Prothrombin Complex Sales and Revenue by Type (2020-2031)
7.4 Europe Human Prothrombin Complex Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human Prothrombin Complex Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Human Prothrombin Complex Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Human Prothrombin Complex Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Human Prothrombin Complex Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Human Prothrombin Complex Sales and Revenue by Type (2020-2031)
9.4 Central and South America Human Prothrombin Complex Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human Prothrombin Complex Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Human Prothrombin Complex Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Human Prothrombin Complex Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human Prothrombin Complex Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Business Overview
11.1.3 Takeda Human Prothrombin Complex Product Models, Descriptions and Specifications
11.1.4 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Takeda Human Prothrombin Complex Sales by Product in 2024
11.1.6 Takeda Human Prothrombin Complex Sales by Application in 2024
11.1.7 Takeda Human Prothrombin Complex Sales by Geographic Area in 2024
11.1.8 Takeda Human Prothrombin Complex SWOT Analysis
11.1.9 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Business Overview
11.2.3 CSL Human Prothrombin Complex Product Models, Descriptions and Specifications
11.2.4 CSL Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 CSL Human Prothrombin Complex Sales by Product in 2024
11.2.6 CSL Human Prothrombin Complex Sales by Application in 2024
11.2.7 CSL Human Prothrombin Complex Sales by Geographic Area in 2024
11.2.8 CSL Human Prothrombin Complex SWOT Analysis
11.2.9 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Business Overview
11.3.3 Grifols Human Prothrombin Complex Product Models, Descriptions and Specifications
11.3.4 Grifols Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Grifols Human Prothrombin Complex Sales by Product in 2024
11.3.6 Grifols Human Prothrombin Complex Sales by Application in 2024
11.3.7 Grifols Human Prothrombin Complex Sales by Geographic Area in 2024
11.3.8 Grifols Human Prothrombin Complex SWOT Analysis
11.3.9 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Human Prothrombin Complex Product Models, Descriptions and Specifications
11.4.4 Octapharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Octapharma Human Prothrombin Complex Sales by Product in 2024
11.4.6 Octapharma Human Prothrombin Complex Sales by Application in 2024
11.4.7 Octapharma Human Prothrombin Complex Sales by Geographic Area in 2024
11.4.8 Octapharma Human Prothrombin Complex SWOT Analysis
11.4.9 Octapharma Recent Developments
11.5 Hualan Biological
11.5.1 Hualan Biological Corporation Information
11.5.2 Hualan Biological Business Overview
11.5.3 Hualan Biological Human Prothrombin Complex Product Models, Descriptions and Specifications
11.5.4 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Hualan Biological Human Prothrombin Complex Sales by Product in 2024
11.5.6 Hualan Biological Human Prothrombin Complex Sales by Application in 2024
11.5.7 Hualan Biological Human Prothrombin Complex Sales by Geographic Area in 2024
11.5.8 Hualan Biological Human Prothrombin Complex SWOT Analysis
11.5.9 Hualan Biological Recent Developments
11.6 Meheco Xinxing Pharma
11.6.1 Meheco Xinxing Pharma Corporation Information
11.6.2 Meheco Xinxing Pharma Business Overview
11.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Product Models, Descriptions and Specifications
11.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Meheco Xinxing Pharma Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Human Prothrombin Complex Industry Chain
12.2 Human Prothrombin Complex Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Human Prothrombin Complex Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Human Prothrombin Complex Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human Prothrombin Complex Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human Prothrombin Complex Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Human Prothrombin Complex Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Human Prothrombin Complex Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Human Prothrombin Complex Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Human Prothrombin Complex Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Human Prothrombin Complex Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Human Prothrombin Complex Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Human Prothrombin Complex Sales by Region (2020-2025) & (K Units)
Table 8. Global Human Prothrombin Complex Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Human Prothrombin Complex Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Human Prothrombin Complex Sales Share by Manufacturers (2020-2025)
Table 12. Global Human Prothrombin Complex Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Human Prothrombin Complex by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)
Table 16. Global Human Prothrombin Complex Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Human Prothrombin Complex Average Selling Price (ASP) by Manufacturers (2020-2025) & (M USD/Unit)
Table 18. Key Manufacturers Human Prothrombin Complex Manufacturing Base and Headquarters
Table 19. Global Human Prothrombin Complex Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 23. Global Human Prothrombin Complex Sales by Type (2026-2031) & (K Units)
Table 24. Global Human Prothrombin Complex Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Human Prothrombin Complex Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Human Prothrombin Complex ASP by Type (2020-2031) & (M USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 29. Global Human Prothrombin Complex Sales by Application (2026-2031) & (K Units)
Table 30. Human Prothrombin Complex High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Human Prothrombin Complex Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Human Prothrombin Complex Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Human Prothrombin Complex ASP by Application (2020-2031) & (M USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Human Prothrombin Complex Growth Accelerators and Market Barriers
Table 37. North America Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Human Prothrombin Complex Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Human Prothrombin Complex Growth Accelerators and Market Barriers
Table 40. Europe Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Human Prothrombin Complex Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Human Prothrombin Complex Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Human Prothrombin Complex Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Human Prothrombin Complex Growth Accelerators and Market Barriers
Table 45. Southeast Asia Human Prothrombin Complex Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Human Prothrombin Complex Investment Opportunities and Key Challenges
Table 47. Central and South America Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Human Prothrombin Complex Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Human Prothrombin Complex Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Takeda Corporation Information
Table 51. Takeda Description and Major Businesses
Table 52. Takeda Product Models, Descriptions and Specifications
Table 53. Takeda Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 54. Takeda Sales Value Proportion by Product in 2024
Table 55. Takeda Sales Value Proportion by Application in 2024
Table 56. Takeda Sales Value Proportion by Geographic Area in 2024
Table 57. Takeda Human Prothrombin Complex SWOT Analysis
Table 58. Takeda Recent Developments
Table 59. CSL Corporation Information
Table 60. CSL Description and Major Businesses
Table 61. CSL Product Models, Descriptions and Specifications
Table 62. CSL Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 63. CSL Sales Value Proportion by Product in 2024
Table 64. CSL Sales Value Proportion by Application in 2024
Table 65. CSL Sales Value Proportion by Geographic Area in 2024
Table 66. CSL Human Prothrombin Complex SWOT Analysis
Table 67. CSL Recent Developments
Table 68. Grifols Corporation Information
Table 69. Grifols Description and Major Businesses
Table 70. Grifols Product Models, Descriptions and Specifications
Table 71. Grifols Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 72. Grifols Sales Value Proportion by Product in 2024
Table 73. Grifols Sales Value Proportion by Application in 2024
Table 74. Grifols Sales Value Proportion by Geographic Area in 2024
Table 75. Grifols Human Prothrombin Complex SWOT Analysis
Table 76. Grifols Recent Developments
Table 77. Octapharma Corporation Information
Table 78. Octapharma Description and Major Businesses
Table 79. Octapharma Product Models, Descriptions and Specifications
Table 80. Octapharma Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 81. Octapharma Sales Value Proportion by Product in 2024
Table 82. Octapharma Sales Value Proportion by Application in 2024
Table 83. Octapharma Sales Value Proportion by Geographic Area in 2024
Table 84. Octapharma Human Prothrombin Complex SWOT Analysis
Table 85. Octapharma Recent Developments
Table 86. Hualan Biological Corporation Information
Table 87. Hualan Biological Description and Major Businesses
Table 88. Hualan Biological Product Models, Descriptions and Specifications
Table 89. Hualan Biological Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 90. Hualan Biological Sales Value Proportion by Product in 2024
Table 91. Hualan Biological Sales Value Proportion by Application in 2024
Table 92. Hualan Biological Sales Value Proportion by Geographic Area in 2024
Table 93. Hualan Biological Human Prothrombin Complex SWOT Analysis
Table 94. Hualan Biological Recent Developments
Table 95. Meheco Xinxing Pharma Corporation Information
Table 96. Meheco Xinxing Pharma Description and Major Businesses
Table 97. Meheco Xinxing Pharma Product Models, Descriptions and Specifications
Table 98. Meheco Xinxing Pharma Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 99. Meheco Xinxing Pharma Recent Developments
Table 100. Key Raw Materials Distribution
Table 101. Raw Materials Key Suppliers
Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 103. Milestones in Production Technology Evolution
Table 104. Distributors List
Table 105. Market Trends and Market Evolution
Table 106. Market Drivers and Opportunities
Table 107. Market Challenges, Risks, and Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 500 IU/Vial Product Picture
Figure 4. 600 IU/Vial Product Picture
Figure 5. 1000 IU/Vial Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Prothrombin Complex Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hemophilia B
Figure 9. Vitamin K Deficiency
Figure 10. Others
Figure 11. Human Prothrombin Complex Report Years Considered
Figure 12. Global Human Prothrombin Complex Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 14. Global Human Prothrombin Complex Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Human Prothrombin Complex Revenue Market Share by Region (2020-2031)
Figure 16. Global Human Prothrombin Complex Sales (2020-2031) & (K Units)
Figure 17. Global Human Prothrombin Complex Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Human Prothrombin Complex Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Human Prothrombin Complex Sales Volume Market Share in 2024
Figure 20. Global Human Prothrombin Complex Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. 500 IU/Vial Revenue Market Share by Manufacturer in 2024
Figure 23. 600 IU/Vial Revenue Market Share by Manufacturer in 2024
Figure 24. 1000 IU/Vial Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global Human Prothrombin Complex Sales Market Share by Type (2020-2031)
Figure 27. Global Human Prothrombin Complex Revenue Market Share by Type (2020-2031)
Figure 28. Global Human Prothrombin Complex Sales Market Share by Application (2020-2031)
Figure 29. Global Human Prothrombin Complex Revenue Market Share by Application (2020-2031)
Figure 30. North America Human Prothrombin Complex Sales YoY (2020-2031) & (K Units)
Figure 31. North America Human Prothrombin Complex Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Human Prothrombin Complex Sales Revenue (US$ Million) in 2024
Figure 33. North America Human Prothrombin Complex Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Human Prothrombin Complex Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Human Prothrombin Complex Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Human Prothrombin Complex Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Human Prothrombin Complex Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Human Prothrombin Complex Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Human Prothrombin Complex Sales Revenue (US$ Million) in 2024
Figure 43. Europe Human Prothrombin Complex Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Human Prothrombin Complex Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Human Prothrombin Complex Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Human Prothrombin Complex Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 48. France Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Human Prothrombin Complex Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Human Prothrombin Complex Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Human Prothrombin Complex Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Human Prothrombin Complex Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Human Prothrombin Complex Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Human Prothrombin Complex Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Human Prothrombin Complex Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 63. India Human Prothrombin Complex Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Human Prothrombin Complex Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Human Prothrombin Complex Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Human Prothrombin Complex Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Human Prothrombin Complex Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Human Prothrombin Complex Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Human Prothrombin Complex Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Human Prothrombin Complex Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Human Prothrombin Complex Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Human Prothrombin Complex Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Human Prothrombin Complex Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Human Prothrombin Complex Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Human Prothrombin Complex Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Human Prothrombin Complex Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Human Prothrombin Complex Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Human Prothrombin Complex Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Human Prothrombin Complex Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Human Prothrombin Complex Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Human Prothrombin Complex Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Human Prothrombin Complex Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Human Prothrombin Complex Revenue (2020-2025) & (US$ Million)
Figure 84. Human Prothrombin Complex Industry Chain Mapping
Figure 85. Regional Human Prothrombin Complex Manufacturing Base Distribution (%)
Figure 86. Global Human Prothrombin Complex Production Market Share by Region (2020-2031)
Figure 87. Human Prothrombin Complex Production Process
Figure 88. Regional Human Prothrombin Complex Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Human Prothrombin Complex in 2025?
The global market size of Human Prothrombin Complex in 2025 was 2177 Million USD.
Which companies rank high in the global Human Prothrombin Complex market?
What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Human Prothrombin Complex in 2031?
Related Reports
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now